Zevra Therapeutics Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Zevra Therapeutics, Inc. regarding possible recoveries of investor losses under federal securities laws [1] Company Investigation - The investigation focuses on the executive officers of Zevra Therapeutics, Inc. and their actions that may have led to investor losses [1] - Investors who purchased Zevra securities and experienced losses are encouraged to join the investigation [1]